DrugPatentWatch Database Preview
ELOCON Drug Profile
» See Plans and Pricing
Which patents cover Elocon, and when can generic versions of Elocon launch?
Elocon is a drug marketed by Merck Sharp Dohme and is included in three NDAs.
The generic ingredient in ELOCON is mometasone furoate. There are thirty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
US ANDA Litigation and Generic Entry Outlook for Elocon
A generic version of ELOCON was approved as mometasone furoate by PERRIGO NEW YORK on March 18th, 2002.
Summary for ELOCON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 67 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,320 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ELOCON |
| DailyMed Link: | ELOCON at DailyMed |
Recent Clinical Trials for ELOCON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| LEO Pharma | Phase 1 |
| University of Oulu | Phase 4 |
| Schering-Plough | Phase 4 |
Pharmacology for ELOCON
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Paragraph IV (Patent) Challenges for ELOCON
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| ELOCON | LOTION;TOPICAL | mometasone furoate | 019796 | 2004-06-10 |
| ELOCON | CREAM;TOPICAL | mometasone furoate | 019625 |
US Patents and Regulatory Information for ELOCON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Merck Sharp Dohme | ELOCON | mometasone furoate | OINTMENT;TOPICAL | 019543-001 | Apr 30, 1987 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Merck Sharp Dohme | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-002 | Apr 19, 2013 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Merck Sharp Dohme | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ELOCON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | Start Trial | Start Trial |
| Merck Sharp Dohme | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | Start Trial | Start Trial |
| Merck Sharp Dohme | ELOCON | mometasone furoate | OINTMENT;TOPICAL | 019543-001 | Apr 30, 1987 | Start Trial | Start Trial |
| Merck Sharp Dohme | ELOCON | mometasone furoate | CREAM;TOPICAL | 019625-001 | May 6, 1987 | Start Trial | Start Trial |
| Merck Sharp Dohme | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ELOCON
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 603837 | Start Trial |
| Greece | 3005762 | Start Trial |
| European Patent Office | 0292893 | Start Trial |
| Norway | 882417 | Start Trial |
| Denmark | 174790 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ELOCON
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0057401 | SPC/GB93/085 | United Kingdom | Start Trial | SPC/GB93/085, EXPIRES: 20050621 |
| 0057401 | 94C0002 | Belgium | Start Trial | PRODUCT NAME: MOMETASONI FUROAS; NAT. REG.: 304 S 131 F 7 19930813; FIRST REG.: GR 10681/89 19900622 |
| 0548114 | SPC/GB97/064 | United Kingdom | Start Trial | PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410 |
| 0057401 | 94C0003 | Belgium | Start Trial | PRODUCT NAME: MOMETASONI FUROAS; NAT REG.: 304 S 132 F 11 19930813; FIRST REG.: GR 10683/89 19900622 |
| 0057401 | 94C0004 | Belgium | Start Trial | PRODUCT NAME: MOMETASONI FUROAS; NAT REG.: 304 S 133 F 7 19930813; FIRST REG.: GR 10682/89 19900622 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
